NCT00481533View on ClinicalTrials.gov

Ergot and Oxytocin During Cesarean Delivery Following Failure to Progress in Labour

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

January 31, 2007

Conditions
Blood Loss, Surgical
Interventions
DRUG

Methyl-Ergonovine-Oxytocin

DRUG

Oxytocin

Trial Locations (1)

M5G 1X5

Mount Sinai Hospital, Toronto

All Listed Sponsors
lead

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

OTHER

NCT00481533 - Ergot and Oxytocin During Cesarean Delivery Following Failure to Progress in Labour | Biotech Hunter | Biotech Hunter